How much more do you need to vaccinate for infections to decrease – News

The combination of restrictions on the movement of people and the arrival, in the last hours, of 843,600 doses of AstraZeneca corresponding to the Covax mechanism and 609,965 injections of component 1 of the Russian vaccine Sputnik V represents a new step towards the approach the threshold that they have already exceeded the aforementioned European countries and which have allowed a gradual opening of their activities and a less stressed health system.

Let’s review what happened in Germany. According to the latest Bloomberg agency report, the Teutonic country vaccinated 39.9% of its population with one dose and 13.7% with two doses.

/ Home of the embed code /

/ End of embed code /

The statistical records that can be seen in these tables indicate that on April 26, Germany experienced its peak of infections, which forced the shutdown of its activities.

A few days later, with 23% of its population inoculated with one dose and 7% with both doses, the curve for new infections began to decline rapidly, day by day, until 1,183 new cases were reported on the 24th. may.

On April 24, Germany reported a number of similar cases to Argentina these days, 24,423 infections.

Then, the sudden reduction in cases occurred, when between 23% and 25% of the inhabitants were vaccinated with two doses and, between 7% and 10%, with both injections.

These figures, which are encouraging for Argentina if it can get hold of vaccines and distribute them quickly, are repeated in Nordic countries such as Sweden and Finland.

In the case of the first country, reluctant to containment during the first wave which led to a health crisis due to the failure of its herd immunity policy, it increased its vaccination rate and recorded on May 20 3,170 new cases. A month earlier, Sweden had 8,873 patients every 24 hours. And, the trend of infected people continues to decline.

According to the agency’s global report Bloomberg, Sweden, has 22% of its population inoculated.

Finland, for its part, it succeeded in vaccinating 2.67 million inhabitants, or 24.2% of its total population, with the particularity of having deployed a campaign to inoculate as many Finns as possible with one dose.

41.5% of its population have already received a first dose while 6.5% have received the two recommended doses.

The health policy consisting in covering the greatest number of inhabitants of a country with the first dose, delaying the second application in time, was a novelty in England.

A policy adopted by the circumstances. Prime Minister Boris Johnson had to adopt this measure during the boreal winter, taking note of the growth of cases during the month of December due to the Kent variant which generated the closure of activities on the European island.

One of the reasons he decided to use existing vaccines as the first dose and postpone the second was due to the productive bottleneck of the AstraZeneca lab and the failure of US labs Pfizer and Moderna to supply the Great -Brittany.

With the stock it managed to muster for the month of April, the English government managed to immunize 45% of its population with one dose and only 7% with both applications.

This high number of first doses allowed all of the restrictions imposed by the quarantine at the end of last year to begin to be lifted by the fourth month of the year.

the UK It is one of the countries that has suffered the most from the consequences of the pandemic on human life. Since its creation, 127,724 people have died.

In 2021, the peak of deaths due to Covid-19 reached it on January 20 with 1,823 inhabitants deceased. After having vaccinated nearly half of its population with one dose, on May 24, it had only 3 deaths and 2,439 new cases. As of January 20, it had registered 38,794 positive cases.

Figures from Argentina indicate that percentage vaccination is approaching those achieved in Germany and the Nordic countries when contagion and death rates began to decline.

the tables Bloomberg they represent 19.4% of compatriots vaccinated with one dose and 5.4% inoculated with the two injections. A result that could be improved with the recent entry of new doses from the Covax fund and AstraZeneca that the administration Alberto Fernández expected to receive from last February.

On the one hand, it is hoped that by improving these vaccination rates, as well as the restrictions decreed on May 21, the second wave will start to lose strength from the next two weeks.

On the other hand, there are doubts about the approaching winter season with colder days than in the season of last year and with the effectiveness of the vaccines used in our country.

While in Germany and Sweden Pfizer and Moderna vaccines have been used, in Argentina Sinopharm and Sputnik V vaccines are used, which in Europe have not been approved by the European Medicines Agency (EMA).

There have been coincidences, when applying doses of the Oxford / AstraZeneca vaccine, present in Europe and South America.

The World Health Organization (WHO) monitors vaccine production processes, and although this 2021 presented many production and distribution issues, the efficiency of the laboratory production process can generate 12 billion doses.

Duke University warns that this may be an optimistic scenario for production managers, but it’s the goal all of the labs have come up with.

The key will therefore be in the equitable distribution of doses among the world’s population. And also in the speed with which they reach all the nations.

It is vital that no one is left behind. Of the 196 countries, 176 have started to vaccinate, of course the vaccination rates are not the same and there are countries which are far behind Israel, the United States, Chile, Saudi Arabia, which are at the top of the ranking for the number of inhabitants of its vaccinated population.

Other countries, such as Australia O New Zealand in Oceania, they prefer to wait for the results of emergency vaccines approved in Europe or North America and then start with a more aggressive vaccination campaign. They can wait because they have the pandemic under control so far.

But vaccine distribution needs to be fair because the emergence and spread of new variants may mean we need a new generation of vaccines before the end of 2021.

We also don’t yet know how long vaccine immunity will last, and we may need booster shots on a regular basis to maintain immunity and target new variants.